Article
Corneal collagen cross-linking halts keratoconus progression
Anaheim, CA-Cross-linking of corneal collagen by topical treatment with riboflavin and ultraviolet (UV) light exposure shows promise as a safe, effective, simple, and inexpensive nonsurgical treatment for keratoconus, said Theo Seiler, MD, PhD, at the annual meeting of the American Academy of Ophthalmology.
Newsletter
Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.
Related Videos
Related Content
